The Board of Henderson Morley plc (“Henderson Morley” or “the Company”),
the drug discovery company, is pleased to announce that its ordinary shares
have been admitted to trading on PLUS Markets (under the same trading
symbol as on AIM: HML). Henderson Morley’s ordinary shares will continue to be quoted and traded
on AIM. Trading through PLUS is intended to enhance investor choice,
improve liquidity for shareholders and provide greater access to investors.
For more information on PLUS, visit www.plusmarketsgroup.com |
